Trials / Completed
CompletedNCT01100476
Mynx M5 One Hour Ambulation Study
Single-center, Post Market, Prospective, Consecutive, Single-arm Study Compared to Historical Control (Diagnostic Arm of the Mynx 6/7F Study)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Cardiovascular Associates of the Delaware Valley · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Mynx Vascular Closure Device (Mynx M5) is a sponge-like material used to close the hole in the artery after patients undergo a diagnostic endovascular procedures
Detailed description
Key Inclusion: 1. Patients \>18 yrs of age 2. Patient underwent a percutaneous diagnostic procedure utilizing a 5F procedural sheath via the common femoral artery. 3. Patient is able to ambulate (routinely walk 6 meters or 20 feet without assistance for any reason) as assessed by investigator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endovascular Diagnostic Procedures | Patients underwent a percutaneous diagnostic procedure utilizing a 5F procedural sheath in the common femoral artery |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2010-04-09
- Last updated
- 2013-02-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01100476. Inclusion in this directory is not an endorsement.